Engineered Commensals as Next-Generation Drug Delivery Agents for Nose-to-Brain Therapeutics in Neurological Disorders
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Vijaylaxmi Saxena und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher. Hauptthemen laut MEDLINE: Drug Delivery Systems, Brain, Nervous System Diseases, Central Nervous System Diseases. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Independent Researcher.
- Division of Paediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, United States.
ORCID-Profile: Shubham Garg
Zitieren
APA
Saxena, V., & Garg, S. (2025). Engineered Commensals as Next-Generation Drug Delivery Agents for Nose-to-Brain Therapeutics in Neurological Disorders. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00874
Vancouver
Saxena V, Garg S. Engineered Commensals as Next-Generation Drug Delivery Agents for Nose-to-Brain Therapeutics in Neurological Disorders. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00874
BibTeX
@article{Saxena2025,
author = {Saxena, Vijaylaxmi and Garg, Shubham},
title = {Engineered Commensals as Next-Generation Drug Delivery Agents for Nose-to-Brain Therapeutics in Neurological Disorders},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00874}
}
EUVIMED